Emerging infectious disease and challenges of social distancing in human and non-human animals
Power 5 Players Re-Raise Question of College Athlete Union
Brazilian Real Crashes on Rate Cuts, Doubts of Economic Recovery
Coho Capital 2Q20 Commentary: SPOT On
Is A COVID-19 Vaccine Our Best Hope?
Ron Paul: COVID-19 Is The New "Terrorism"
USD/CAD mini-rally continues
Vaping linked to risk of COVID-19 in teens, young adults
A quick, cost-effective method to track the spread of COVID-19
Covid-19 roundup: Researchers call out Gilead for diversity of remdesivir trials in NEJM; Mexico in vaccine dose, trial talks
Pandemic, Protests, and Economic Collapse: A Time of Testing for Law Enforcement
Scientists identify hundreds of drug candidates to treat COVID-19
"Hard Times Are Here": UK Economy Suffers Record Collapse As GDP Plummets To 2003 Levels
Canada is not immune to the politics of coronavirus masks
No ‘back to normal’ after COVID-19: Health care should shift focus from treatment to prevention
As schools prepare to reopen during COVID-19, are the kids alright?
UK's new insolvency process should worry company creditors around the world
Zoom meetings help marginalised staff feel included – we should keep having them even after offices reopen
The Impact Of The Coronavirus Pandemic On Tech Stocks
Fiscal Response to the Pandemic
Eli Lilly, Innovent’s TYVYT Expanded Use Application Accepted In China
MLB trade rumors and news: Tensions rise amid fallout from Indians’ safety protocol violation scandal
Futures Rebound Back Near All Time Highs, Precious Metals Bounce After Crash
How the old-fashioned telephone could become a new way for some to see their doctor
Movie theaters are on life support – how will the film industry adapt?
A COVID-19 vaccine needs the public's trust – and it's risky to cut corners on clinical trials, as Russia is
"Financially Devastated" - 83% Of NYC Restaurants Unable To Pay July Rent
American Airlines Shares Lifted By Air Travel Demand Data
Malaria Treatment May Be Found by Targeting the Host
U.S. inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine